Your browser doesn't support javascript.
loading
Natural Adeno-Associated Virus Serotypes and Engineered Adeno-Associated Virus Capsid Variants: Tropism Differences and Mechanistic Insights.
Lopez-Gordo, Estrella; Chamberlain, Kyle; Riyad, Jalish Mahmud; Kohlbrenner, Erik; Weber, Thomas.
Afiliación
  • Lopez-Gordo E; Affinia Therapeutics, Waltham, MA 02453, USA.
  • Chamberlain K; Affinia Therapeutics, Waltham, MA 02453, USA.
  • Riyad JM; Independent Researcher, South Plainfield, NJ 07080, USA.
  • Kohlbrenner E; Spark Therapeutics, Philadelphia, PA 19104, USA.
  • Weber T; Spark Therapeutics, Philadelphia, PA 19104, USA.
Viruses ; 16(3)2024 03 12.
Article en En | MEDLINE | ID: mdl-38543807
ABSTRACT
Today, adeno-associated virus (AAV)-based vectors are arguably the most promising in vivo gene delivery vehicles for durable therapeutic gene expression. Advances in molecular engineering, high-throughput screening platforms, and computational techniques have resulted in a toolbox of capsid variants with enhanced performance over parental serotypes. Despite their considerable promise and emerging clinical success, there are still obstacles hindering their broader use, including limited transduction capabilities, tissue/cell type-specific tropism and penetration into tissues through anatomical barriers, off-target tissue biodistribution, intracellular degradation, immune recognition, and a lack of translatability from preclinical models to clinical settings. Here, we first describe the transduction mechanisms of natural AAV serotypes and explore the current understanding of the systemic and cellular hurdles to efficient transduction. We then outline progress in developing designer AAV capsid variants, highlighting the seminal discoveries of variants which can transduce the central nervous system upon systemic administration, and, to a lesser extent, discuss the targeting of the peripheral nervous system, eye, ear, lung, liver, heart, and skeletal muscle, emphasizing their tissue and cell specificity and translational promise. In particular, we dive deeper into the molecular mechanisms behind their enhanced properties, with a focus on their engagement with host cell receptors previously inaccessible to natural AAV serotypes. Finally, we summarize the main findings of our review and discuss future directions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cápside / Dependovirus Idioma: En Revista: Viruses Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cápside / Dependovirus Idioma: En Revista: Viruses Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza